Cowealth Medical China Co.Ltd. (603122) — Cash Flow Reinvestment Rate

Latest as of December 2025: 8.06x

Cowealth Medical China Co.Ltd. (603122) has a Cash Flow Reinvestment Rate of 8.06x as of December 2025, reinvesting CN¥142.58 Million (capex CN¥14.21 Million plus investments CN¥-128.37 Million) from operating cash flow of CN¥17.68 Million. See Cowealth Medical China Co.Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

8.06x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥142.58 Million
Capex + Investments

Operating Cash Flow

CN¥17.68 Million
CNY

Capital Expenditures

CN¥14.21 Million
CNY

Cowealth Medical China Co.Ltd. Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for Cowealth Medical China Co.Ltd. across 5 annual periods. For the full cash flow conversion analysis, see Cowealth Medical China Co.Ltd. (603122) cash flow conversion.

Annual Cash Flow Reinvestment Rate for Cowealth Medical China Co.Ltd. (2020–2025)

Year-by-year capital reinvestment analysis for Cowealth Medical China Co.Ltd.. See financial flexibility index of Cowealth Medical China Co.Ltd. to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 8.06x CN¥142.58 Million CN¥17.68 Million CN¥14.21 Million ▲ +1663.2%
2024 0.46x CN¥60.72 Million CN¥132.75 Million CN¥31.82 Million ▼ -93.5%
2023 7.02x CN¥79.21 Million CN¥11.28 Million CN¥67.96 Million ▲ +24.5%
2021 5.64x CN¥39.55 Million CN¥7.01 Million CN¥22.12 Million ▲ +181.0%
2020 2.01x CN¥148.85 Million CN¥74.15 Million CN¥8.11 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow